Form 4: Evolent Health CEO Seth Blackley Acquires Additional Shares
SEC Form 4 Filing
Evolent Health's CEO, Seth Blackley, recently purchased 55,225 shares of Class A Common Stock at an average price of $9.01.
Summary
- On March 6, 2025, Seth Blackley, the CEO of Evolent Health, Inc., acquired 55,225 shares of Class A Common Stock.
- The shares were purchased at a weighted average price of $9.01, with individual transaction prices ranging from $8.74 to $9.34.
- Following the transaction, Blackley directly owns 762,217 shares of Evolent Health, Inc.
- This total includes restricted stock units granted under awards previously reported to the Securities and Exchange Commission.
Sentiment
Score: 6
Explanation: Neutral sentiment. The document simply reports a transaction. The CEO's purchase could be seen as a positive signal, but it's not overwhelmingly so.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The CEO's stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of the stock purchase transaction. |
| 03/10/2025 | Date of the signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.